Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals Says Shareholders Of Cohance Will Be Issued Shares Of Co At Ratio Of 11 Shares Of Co For Every 295 Shares Of Cohance

Feb 29 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * SUVEN PHARMACEUTICALS -  SHAREHOLDERS OF COHANCE WILL BE
ISSUED
SHARES OF CO AT RATIO OF 11 SHARES OF CO FOR EVERY 295 SHARES OF
COHANCE
    * SUVEN PHARMACEUTICALS - NEW SHARES OF SUVEN ISSUED WILL BE
TRADED ON NSE AND BSE
    * SUVEN PHARMACEUTICALS - ADVENT ENTITIES SHALL OWN ABOUT
66.7%
AND PUBLIC SHAREHOLDERS WILL HOLD ABOUT 33.3% OF COMBINED ENTITY
    * SUVEN PHARMACEUTICALS - TRANSACTION EXPECTED TO CONCLUDE
OVER
NEXT 12-15 MONTHS

Source text for Eikon:  ID:nBSE76tfM9 
Further company coverage:  SUVH.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news